Plain-English translation of NCT05598723 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether or works better for people with chronic migraines. Both are botulinum toxin injections given in the head and neck area. The study will compare how well each medication reduces headache days over six months.
Chronic migraines can be severely disabling, and some people don't respond well to standard migraine medications. This trial aims to determine which of these two botulinum toxin treatments is more effective at reducing the number of migraine days people experience.
You likely qualify if…
You likely don't qualify if…
You would receive 31 small injections in your head and neck area, then return 12 weeks later for a second round of injections. Throughout the study, you would use an electronic diary to record your headache days, severity, and any side effects. You would also complete questionnaires about how your migraines affect your quality of life at the start, at 12 weeks, and at 24 weeks. The study lasts about 6 months total.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States